Search Results - "LE BUANEC, H"

Type I interferon response and vascular alteration in chilblain‐like lesions during the COVID‐19 outbreak by Frumholtz, L., Bouaziz, J.‐D., Battistella, M., Hadjadj, J., Chocron, R., Bengoufa, D., Le Buanec, H., Barnabei, L., Meynier, S., Schwartz, O., Grzelak, L., Smith, N., Charbit, B., Duffy, D., Yatim, N., Calugareanu, A., Philippe, A., Guerin, C.L., Joly, B., Siguret, V., Jaume, L., Bachelez, H., Bagot, M., Rieux‐Laucat, F., Maylin, S., Legoff, J., Delaugerre, C., Gendron, N., Smadja, D.M., Cassius, C.

“…Summary Background The outbreak of chilblain‐like lesions (CLL) during the COVID‐19 pandemic has been reported extensively, potentially related to SARS‐CoV‐2…”
Get full text

Analysis of T‐cell responses directed against the spike and/or membrane and/or nucleocapsid proteins in patients with chilblain‐like lesions during the COVID‐19 pandemic by Cassius, C., Merandet, M., Frumholtz, L., Bergerat, D., Samri, A., Grolleau, C., Grzelak, L., Schwartz, O., Yatim, N., Moghadam, P., Jaume, L., Bagot, M., Legoff, J., Delaugerre, C., Bouaziz, J.‐D., Le Buanec, H.

Get full text

IL-10 producing regulatory B cells in mice and humans: state of the art by Bouaziz, J-D, Le Buanec, H, Saussine, A, Bensussan, A, Bagot, M

“…IL-10-producing regulatory B cells have been undoubtedly identified in mice and shown to downregulate inflammation, making them potentially important for…”
Get more information

Clinical efficacy of selective JAK1 inhibition and transcriptome analysis of chronic discoid lupus erythematosus by Calugareanu, A., Grolleau, C., Le Buanec, H., Chasset, F., Jachiet, M., Battistella, M., Bagot, M., Jullien, D., Poutrel, S., Bouaziz, J.‐D., Ben Said, B.

Get full text

Active versus passive anti-cytokine antibody therapy against cytokine-associated chronic diseases by Zagury, D, Le Buanec, H, Bizzini, B, Burny, A, Lewis, G, Gallo, R.C

“…Current therapeutic vaccine trials in major chronic diseases including AIDS, cancer, allergy and autoimmunity, target antigenic pathogens but not the…”
Get full text

Lectin production by human T-lymphocytes by Lachgar, A., Buanec, H. Le, Burny, A., Bizzini, B., Zagury, D.

“…Cultured human peripheral blood monocytes (PBMC) and the cell line H9 release a lectin. This lectin is not the previously described sarcolectin, since it does…”
Get full text

Important B-cell epitopes for neutralization of human immunodeficiency virus type 1 Tat in serum samples of humans and different animal species immunized with Tat protein or peptides by Moreau, E, Belliard, G, Partidos, C. D, Pradezinsky, F, Le Buanec, H, Muller, S, Desgranges, C

“…1 E03-34 INSERM, Institut de Génétique Moléculaire, Hôpital St Louis, 27 rue Juliette Dodu, 75010 Paris, France 2 UPR9021 CNRS, Institut de Biologie…”
Get full text

Procedures for preparing biologically inactive, but immunogenic HIV-1 Tat protein (Tat toxoid) for human use by Le Buanec, H., Bizzini, B.

“…Extracellular Tat can exercise its deleterious effects on cells surrounding HIV-1-infected cells and allow spreading of virus. Extracellular Tat should be…”
Get full text

345 Instrument-free single-cell RNA sequencing of immune cells in skin inflammatory diseases by Grolleau, C., Poisot, T., Poncin, R., Lipin, S., André, B., Demouche, S., Chaumat, P., Komatsu, J., Bouaziz, J., Le Buanec, H.

Get full text

279 Instrument-free single-cell resolution of transcriptome in human skin by Demouche, S., Poncin, R., Grolleau, C., Merandet, M., Bergerat, D., Majello, S., Dimitrova, D., Lipin, S., Bouaziz, J., Le Buanec, H.

Get full text

The human CD3 g gene promoter is controlled by an RNA element that binds P-TEFb and is negatively regulated by HIV-1 Tat by Badran, BM, Ravoet, M, Akl, H, Dobirta, G, Equeter, C, Manfouo-Foutsop, G, Stamatopoulos, B, Le Buanec, H, Burny, A, Willard-Gallo, KE

Get full text

023 RNA sequencing of chronic GVHD skin lesions identifies TREM1 as a possible therapeutic traget in lichen planus by Calugareanu, A., Lemasson, J., Zouali, H., Battail, C., Le Buanec, H., Peffault de La Tour, R., Bagot, M., Deleuze, J., Socié, G., Bouaziz, J.

Get full text

Selective Activation of Cervical Microvascular Endothelial Cells by Human Papillomavirus 16-E7 Oncoprotein by D'Anna, Rossella, Le Buanec, Hélène, Alessandri, Giulio, Caruso, Arnaldo, Burny, Arsène, Gallo, Robert, Zagury, Jean-François, Zagury, Daniel, D'Alessio, Patrizia

“…Background: Human papillomavirus type 16 (HPV16) is strongly implicated in the etiology of cervical cancer, with the expression of HPV16-encoded E7 oncoprotein…”
Get full text

Therapeutic vaccine to control stromal tumor-induced immunosuppression in human uterine cervixc cancer by Le Buanec, H, Cohen, L, Paturance, S, Burny, A, Gallo, R C, Zagury, D

“…Cancer cells may escape immune surveillance by secreting in their microenvironment soluble factors that may locally paralyze the stromal effector immune cells…”
Get more information

HPV-16 E7 but not E6 oncogenic protein triggers both cellular immunosuppression and angiogenic processes by Le Buanec, H., D'Anna, R., Lachgar, A., Zagury, J.F., Bernard, J., Ittelé, D., d'Alessio, P., Hallez, S., Giannouli, C., Burny, A., Bizzini, B., Gallo, R.C., Zagury, D.

“…HPV-16 E6 and E7 oncoproteins impair the cell cycle in human uterine cervix carcinoma cells (HUCC) by acting on p53 and retinoblastoma proteins, respectively…”
Get full text

043 Persistent deficiency of mucosal associated invariant T cells in dermatomyositis by Cassius, C., Branchtein, M., Battistella, M., Lepelletier, C., De Masson, A., Bensussan, A., Bagot, M., Le Buanec, H., Bouaziz, J.

Get full text

Induction in mice of anti-Tat mucosal immunity by the intranasal and oral routes by Le Buanec, H, Vetu, C, Lachgar, A, Benoît, M.A, Gillard, J, Paturance, S, Aucouturier, J, Gane, V, Zagury, D, Bizzini, B

“…Anti-Tat vaccination experiments were carried out in mice with a view to inducing systemic in addition to mucosal immunity. For this, three types of immunizing…”
Get full text

042 MDA5+ dermatomyositis is associated with stronger skin type I interferon transcriptomic signature with up-regulation of IFN-κ transcript by Cassius, C., Amode, R., Delord, M., Battistella, M., Lepelletier, C., Alberdi, A., Bensussan, A., Bagot, M., Le Buanec, H., Bouaziz, J.

Get full text

467 Immunological signature of amyopathic dermatomyositis by Cassius, C., Amode, R., Jachier, M., Branchtein, M., Bagot, M., Battistella, M., Le Buanec, H., Bouaziz, J.

Get full text

Induction of cellular immunosuppression by the human papillomavirus type 16 E7 oncogenic protein by Le Buanec, H., Lachgar, A., D'Anna, R., Zagury, J.F., Bizzini, B., Bernard, J., Ittelé, D., Hallez, S., Giannouli, N., Burny, A., Zagury, D.

“…The human papillomavirus type 16 (HPV-16) E7 oncogenic protein is found in the culture supernatant of SiHa cells, a cervical carcinoma cell line. Extracellular…”
Get full text